More recent studies, however, demonstrate the importance of CD4+ T cells in anti-tumor responses, with a number of clinical and experimental studies reporting cytotoxic CD4+ T cells recognizing tumor neoantigens and or self-antigens [37,38,39]. The gene discussed is CD4; the disease is neoplasm.